FAST
49
3
ECL
72
3
T
54
-6
JBHT
56
6
SCHW
49
4
PBI
53
-9
AMAT
55
6
FRT
38
-3
DE
45
5
QRVO
38
5
GS
69
4
VTR
47
-8
TROW
39
4
TMO
60
2
WAT
52
3
MCD
65
2
KIM
57
6
JCI
54
2
AVB
67
2
GPC
51
13
FAST
49
3
ECL
72
3
T
54
-6
JBHT
56
6
SCHW
49
4
PBI
53
-9
AMAT
55
6
FRT
38
-3
DE
45
5
QRVO
38
5
GS
69
4
VTR
47
-8
TROW
39
4
TMO
60
2
WAT
52
3
MCD
65
2
KIM
57
6
JCI
54
2
AVB
67
2
GPC
51
13
Financhill
Back

scPharmaceuticals Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

SCPH
scPharmaceuticals

Last Price:
5.26
Seasonality Move:
-14.35%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

scPharmaceuticals Price Quote

$5.26

scPharmaceuticals Key Stats

Sell
25
scPharmaceuticals (SCPH) is a Sell
Day range:
$5.17 - $5.63
52-week range:
$3.24 - $7.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.50
P/B ratio:
28.45%
Volume:
230.7K
Avg. volume:
351.2K
1-year change:
-27.85%
Market cap:
$263.2M
Revenue:
$13.6M
EPS:
$-1.56

How Much Does scPharmaceuticals Make?

Is scPharmaceuticals Growing As A Company?

  • What Is scPharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.92%
  • What Is scPharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

scPharmaceuticals Stock Price Performance

What Is scPharmaceuticals 52-Week High & Low?

scPharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy scPharmaceuticals?

  • How Much Debt Does scPharmaceuticals Have?
    Total long term debt quarterly is $40M
  • How Much Cash Does scPharmaceuticals Have?
    Cash and short term investments quarterly total is $38.5M
  • What Is scPharmaceuticals’s Book Value Per Share?
    Book value per share is 0.26

Is scPharmaceuticals Cash Flow Positive?

  • What Is SCPH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$66.5M
  • What Is scPharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $833K
  • What Is scPharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $32.9M

scPharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    SCPH return on invested capital is -80.26%
  • What Is scPharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -66.11%
  • What Is SCPH Return On Equity?
    ROE is a measure of profitability and is -165.15%

scPharmaceuticals Earnings Date & Stock Price

scPharmaceuticals Competitors

  • Who Are scPharmaceuticals's Competitors?
    Below is a list of companies who compete with scPharmaceuticals or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)
    • Verrica Pharmaceuticals Inc (VRCA)

scPharmaceuticals Dividend Yield

scPharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.28%
Revenue: 391.7% 1.06%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.80
Upside from Last Price: 276.43%

Major Shareholders

  • How many SCPH shares are owned by institutional investors?
    39.5M SCPH shares are owned by institutional investors
  • How many SCPH shares are owned by insiders?
    400.9K SCPH shares are owned by insiders